Franz Vollenweider: 5HT2A Receptor Agonists & Mood Disorders – Mood, Empathy & Social Pain



Learn more and donate: http://www.maps.org/

Franz Vollenweider, MD
Psychedelic 5HT2A Receptor Agonists
Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

Bruno Gomes: Plant or Psychedelic Medicine? Understanding the Ayahuasca & Ibogaine Healing Process



Learn more and donate: http://www.maps.org/

Bruno Gomes, MA
Plant Medicine or Psychedelic Medicine? Understanding the Healing Processes with Ayahuasca and Ibogaine

2017 Psychedelic Science Conference
http://psychedelicscience.org/
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

source

Continue Reading →

Rick Doblin, Ph.D. Shares his Ibogaine Experience

Rick Doblin, Ph.D. Founder of psychedelic research group MAPS, talks about his experience with Ibogaine and LSD, in order to confront his own shadows and be more effective as a political activist.

Connect with Rick: http://www.maps.org | rick@maps.org

Also featuring Alan Steinfeld who assisted in the interviewing of Rick.
Connect with Alan: http://www.newrealities.com | newrealities@earthlink.net

source

Continue Reading →
Page 2 of 2 12
UA-77446339-1